Live Breaking News & Updates on Angela Luan|Page 1
Stay updated with breaking news from Angela luan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LOTUS REPORTS ITS BEST QUARTER EVER WITH THE BIGGEST LAUNCH IN ITS HISTORY dkoding.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dkoding.in Daily Mail and Mail on Sunday newspapers.
PTT Invests in Lotus Pharmaceutical s Strategic Partnership in South East Asia Tuesday, April 20, 2021 10:30AM IST (5:00AM GMT)
The transaction creates a very strong platform to expand market access in the ASEAN region. Both parties are committed to further collaboration to provide patients with better access to high quality medicines across the region.
Lotus Pharmaceutical Co., Ltd. (“Lotus” or “the Company”, Taiwan TWSE ticker: 1795), an Alvogen company, has announced the issuance of new shares through private placement to be acquired by Innobic (Asia). The move is aimed at further strengthening the company’s market access in the ASEAN region. Innobic (Asia) is a wholly owned subsidiary of PTT Public Company Limited (“PTT”, SET ticker: PTT), the largest publicly listed conglomerate in Thailand. PTT, whose majority owner is the Ministry of Finance in Thailand, is the nation s only company listed in the Fortune Global 500. ....
PTT Invests in Lotus Pharmaceutical's Strategic Partnership in South East Asia apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Lotus revenue hits record on exports By Kao Shih-ching / Staff reporter Lotus Pharmaceutical Co (美時化學製藥), one of the nation’s leading specialty generic drug developers, yesterday said revenue last year hit a record NT$10.58 billion (US$371.4 million) on the back of robust exports. Revenue last year rose 15 percent annually, despite plummeting 41.7 percent last month to NT$1.01 billion, which could be attributed to a high comparison base in 2019 due to higher sales of gSuboxone, a company official said by telephone. GSuboxone is the generic version of Indivior Inc’s Suboxone used in the treatment of opioid use disorder, company data showed. “Although falling annually, December’s revenue still stood at a comparatively high level. It was the fifth month with revenue of more than NT$1 billion last year,” Lotus Pharmaceutical director of corporate finance and investor relations Angela Luan (欒君儀) said. ....